Hypersensitivity to insulin;Hypersensibilité aux insulines

Presse Medicale

Volumn 33, Issue 9 I, 2004, Pages 631-638

  Messaad, Djamel ^a   Outtas, Omar ^a   Demoly, Pascal ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BASAL OPTISET; BOVINE INSULIN; COMB 15 OPTIPEN; COMB 15 OPTISET; COMB 25 OPTIPEN; COMB 50 OPTISET; COMB OPTIPEN; CORTICOSTEROID; HUMALOG MIX; HUMALOG PEN; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; NEUTRAL INSULIN; NOVOLET; PENFILL; PIG INSULIN; PROTAMINE; RAPID OPTIPEN; RAPID OPTISET; RECOMBINANT HUMAN INSULIN; UMULINE PEN; UNCLASSIFIED DRUG; VELOSULINE;

CROSS REACTION; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG TOLERANCE; ECZEMA; ERYTHEMA; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INJECTION; PAPULE; PURPURA; REMISSION; REVIEW; SKIN MANIFESTATION; SKIN TEST;

EID: 2942736905     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(04)98691-5     Document Type: Short Survey

References (92)

1. Martinalde. The complete drug reference, thirty-second edition 1999, ed Kathleen Parfitt BSc, FRPharmaS, p 322.
2. Human insulin, Therapeutic DRUGS 1991, Sir Collin Dollery. ed Churchill Livingstone, Edinburgh pp136-9.
3. Barbaud A, Got I, Trechot P, Noirez V, Schmutz JL. Allergies cutanées et insulinothérapie, aspects récents, conduite à tenir. Ann Dermatol Vénéréol 1996; 123: 214-18.
4. Williams JR. Clinical study of effects of insulin in severe diabetes. J Metab Res 1922; 2: 729-51.
5. Lawrence RD. Local insulins reactions. Lancet 1925; 1: 1125-6.
6. Grammer LC. Immunologic reaction to insulin and other proteins. Immunol Allergy Clin North Am 1998; 18: 809-16.
7. Hanauer L, Baston JM. Anaphylactic shock following insulin injection. Diabetes 1961; 10: 105-9.
8. Grammer L. Insulin allergy. Clin Rev Allergy 1986; 4: 189-200.
9. Ross JM. Allergy to insulin. Pediatr Clin North Am 1984; 31: 675-87.
10. Bollinger ME, Hamilton RG, Wood RA. Protamine allergy as a complication of insulin hypersensitivity: A case report. J Allergy Clin Immunol 1999; 104: 462-5.
11. Grüneklee D. Die insulin allergy. Intern Welt 1980; 12: 442-50.
12. Schemthaner G. Immunogenicity and allergenic potential of animal and humain insulins. Diabetes Care 1993; 16 Suppl 3: 155-65.
13. Altman JJ, Pehuet M, Slama G, Tchobroutsky C. Three cases of allergic reaction to huamin insulin. Lancet 1983, 27: 2: 524.
14. Wiles PG, Guy R, Watkins SM, Reeves WG. Allergy to purified bovine, porcine, and human insulins. Br Med J 1983, 287: 531.
15. Kumar D, Kamdar W, Miller LV. Systemic allergic reactions to human insulin. Diabetes 1984; 33: 87
16. Gossain W, Rovner DR, Mohan K. Systemic allergy to human (recombinant DNA) insulin. Ann Allergy 1985; 55: 116-18.
17. Grammer LC, Metzger BE, Patterson R. Cutaneous allergy to human (recombinant DNA) insulin. JAMA 1984; 251: 1459-60.
18. Grammer LC, Roberts M, Buchanan TA, Fitzsimous R, Metzger BE, Patterson R. Specificity of immunoglobulin E and immunoglobulin G against human (recombinant DNA) insulin in human insulin allergy and resistance. J Lab Clin Med 1987; 109: 141-6.
19. Ratner RE, Phillips TM, Steiner M. Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes 1990; 39: 728-33.
20. Balsells MC, Corcoy RM, Lleonart RB et al. Primary allergy to human insulin patient with gestational diabetes. Diabetes Care 1991; 14: 423-4.
21. Gonzalo MA, De Argila D, Revenga F, Garcia JM, Diaz J, Morales F. Cutaneous allergy to human (recombinant DNA) insulin. Allergy 1998; 53: 106-7.
22. Yasuna E. Generaled allergic reactions to insulin. J Allergy 1941; 12: 295-306.
23. Kumar D. Anti-insulin IgE in diabetics. J Clin Endocrinol Metab 1977; 45: 1159-64.
24. Mattson JR, Patterson R, Roberts M. Insulin therapy in patients with systematic insulin allergy. Arch Intern Med 1975; 135: 818-21.
25. Lieberman P, Patterson R, Metz R, Uucena G. Allergic reactions to insulins. JAMA 1971; 215: 1106-12.
26. Grammer LC, Chen PY, Patterson R. Evaluation and management of insulin allergy. J Allergy Clin Immunol 1983; 71: 250-4.
27. Skyler JS. A plethora of insulins. Diabetes Care 1980; 3: 638-9.
28. Fineberg SE, Galloway JA, Fineberg NS, Rathburn MJ. Immunologic improvement resulting from transfer of animal insulin-treated diabetic subjects to human insulin (recombinat DNA). Diabetes Care 1982; 5: S107-13.
29. Grammer LC, Roberts M, Patterson R. IgE and IgG antibody against human (recombinant DNA) insulin in patients with systemic insulin allergy. J Lab Clin Med 1985; 105: 108-13.
30. Patterson R, Lucena G, Metz P, Roberts M. Reaginic antibody against insulin: demonstration of antigenic distinction between native and extracted insulin. J Immunol 1969; 103: 1061-71.
31. Schernthaner G, Ludwig H, Jarisch R, Bruneder H. Immediate-type allergy against insulin itself: clinical and immunologic studies on a diabetic patient with insulin intolerance. Diabetes Care 1981; 4: 196-201.
32. deShazo RD, Mather P, Grant W et al. Evaluation of patients with local reactions to insulin with skin test and in vitro techniques. Diabetes Care 1987; 10: 330-36.
33. Davidson JA, Galloway JA, Petersen BH, Wentworth SM, Crabtree RE The use of purified insulins in insulin allergy. Diabetes 1974; 23: A352.
34. Wurzburger MI, Prelevic GM et al. Delaved-type allergy against various insulin preparations including human semisynthetic insulin. Ann Allergy 1987; 59: 44-7.
35. deShazo RD, Boehm TM, Kumar D, Galloway JA, Dvorak HF. Dermal hypersensitivity reactions to insulin: correlation of three patterns to their histopathology. J Allergy Clin Immunol 1982; 69: 229-37.
36. Patterson R, O'Rourke I, Roberts M, Suszko IM. Immunologic reactions against insulin: IgG anti-insulin and insulin reactions. J Immunol 1973; 110: 1126-34.
37. Tater D, Yoninou P, Zirinis P, Codet JP, Bercovici JP, Bottazo GF. Circulating immune complexes containing bovine insulin in a patient with systemic allergic manifestations. Diabetes Res Clin Pract 1987; 3: 285-9.
38. deShazo RD, Levinson Al, Boehm T, Evans R 3rd, Ward GJr. Severe persistant biphasic local (immediate and late) skin reactions to J insulin. J Allergy Clin Immunol 1977; 59: 161-4.
39. Loeb JA, Herold KC, Barton KP, Robinson LE, Jaspan JB. Systematic approach to diagnosis and management of biphasic insulin allergy with local anti-inflammatory agents. Diabetes Care 1989; 12: 421-3.
40. deShazo RD, Levinson Al, Dvorak HF, Davis RW. The late phase skin reaction: evidence for activation of he coagulation system in a IgE-dependant reaction in man. J Immunol 1979; 122: 692-8.
41. Solley GO, Gleich GJ, Jordon RE, Schmeter AL. The late phase of the immediate wheal and flare kin reaction. Its dependence upon IgE antibodies. J Clin Invest 1976; 58: 408-20.
42. Blanco C, Castillo R, Quiralte J et al. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin. Allergy 1996; 51: 421-4.
43. Vermeulen C. Les allergies à l'insuline. Sem Höp Paris 1981; 57: 1527-34.
44. Perez MG, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1994; 30: 519-31.
45. Hulshof MM, Faber WR, Kniestedt WF, Boeree MJ, Kreek P. Granulomatous hypersensitivity to protamine as a complication of insulin therapy. BrJ Dermatol 1992; 127: 286-8.
46. Lamkin N, Lieberman P, Hashimoto K, Morohashi M, Sullivan P. Clinical conference: Allergic reactions to insulin. J Allergy Clin Immunol 1976; 58: 213-23.
47. Arkins JA, Engbring NH, Lennon EJ. The incidence of skin reactivity to insulin in diabetic patients. J Allergy 1962; 33: 69-72.
48. Lee AY, Chey WY, Choi J, Jeon JS. Insulin-induced drug eruptions and reliability of skin tests. Acta Derm Venerol 2002; 82: 114-17.
49. Ross JM. Allergy to insulin. Pediatr Clin North Am 1984; 31: 675-87.
50. Panczel P, Hosszufalusi N, Horvath MM, Horvath A. Advantage of insulin lispro in suspected insulin allergy. Allergy 2000; 55: 409-10.
51. Berson SA, Yalow RS, Bauman A, Rothschild MA, Newedy K. Insulin-/131 metabolism in human subjects. Demonstrations of insulin binding globulin in circulation of insulin-treated subjects. J Clin Invest 1956; 35: 170-90.
52. Chance RE, Root MA, Galloway JA. The immunogenicity of insulin preparations. Acta Endocrinol Suppl (Copenh) 1976; 205: 185-98.
53. Schernthaner G, Borkenstein M, Fink M, Mayr WR, Menzel J, Schober E. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Diabetes Care 1983; 6: S43-48.
54. Fineberg SE, Galloway JA, Fineberg NS, Rathbun MJ, Hufferd S. Immunogenicity of recombinant DNA insulin. Diabetologia 1983; 25: 465-9.
55. Mattson JR, Patterson R, Roberts M. Insulin therapy in patients with systemic insulin allergy. Arch Intern Med 1975; 135: 818-21.
56. Cobb CA 3rd, Fung DL. Shock due to protamine hypersensitivity. Surg Neurol 1982; 17: 245-6.
57. Stewart WJ, Mc Sweeney SM, Kellet MA, Faxon DP, Ryan TJ. Increased risk of severe protamine reactions in NPH insulin-dependant diabetics undergoing cardiac catheterization. Circulation 1984; 70: 788-92.
58. Porsche R, Brenner ZR. Allergy to protamine sulfate. Heart Lung 1999; 28: 418-28.
59. Dykewicz MS, Kim HW, Orfan N, Yoo TJ, Lieberman P. Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin. J Allergy Clin Immunol 1994; 93: 117-25.
60. Sanchez MB, Paolillo M, Chacon RS, Camejo M. Protamine as a cause of generalised allergic reactions to NPH insulin. Lancet 1982; 1: 1243.
61. Kollner A, Senff H, Engelmann L, Kalveram KJ, Velcovsky HG, Haneke E. Delayed hypersensitivity to protamine and immediate hypersensitivity to insulin. Dutsch Med Wochenschr 1991; 116: 1234-8.
62. Weiler JM, Gellhaus MA, Carter JG. A prospective study of the risk an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery. J Allergy Clin Immunol 1990; 85: 713-19.
63. Weiss ME, Chatham F, Kagey-Sobotka A, Adkinson NF Jr. Serial immunological investigations in a patient who had a life-threatening reaction to intravenous protamine. Clin Exp Allergy 1990; 20: 713-20.
64. Feinglos MN, Jegasothy BV. "Insulin" allergy due to zinc. Lancet 1979; 1: 112-4.
65. Bruni S, Barolo P, Gamba S, Grassi O, Blatto A. Case of generalized allergy due to zinc and protamine in insulin preparation. Diabetes care 1986; 9: 552.
66. Gin H, Aubertin J. Generalized allergy due to zinc and protamine in insulin preparation treated with insulin pump. Diabetes Care 1987; 10: 789-90.
67. Brooks AP, Roseveare CD. Cutaneous allergy (urticaria) to insulin preparations. Pratical Diabetes 1994; 11: 236-39.
68. MacCracken J, Stenger P, Jackson T. Latex allergy in diabetic patients: a call for latex-free insulin tops. Diabetes Care 1996; 19: 184.
69. Towse A, O'Brien M, Twarog FJ, Braimon J, Moses AC. Latex reaction secondary to insulin injection. A potential role for latex antigens in insulin vials and syringes. Diabetes Care 1995; 18: 1195-7.
70. Hoffman RP. Latex hypersensitivity in a child with diabetes. Arch Pediatr Adolesc Med 2000; 154: 281-2.
71. van den Hove J, Jacobs MC, Tennstedt D, Lachapelle JM. Allergic contact dermatitis from acrylates in insulin pump infusion sets. Contact Dermatitis 1996; 35: 108.
72. Busschots AM, Meuleman V, Poesen N, Dooms-Goossens A. Contact allergy to components of glue in insulin pump infusion sets. Contact Dermatitis 1995; 33: 205-6.
73. Saccabusi S, Boatto G, Asproni B, Pau A. Sensitization to methyl methacrylate in plastic catheter of an insulin pump infusion set. Contact Dermatitis 2001; 45: 47-8.
74. Jolanki R, Kanerva L, Estlander T, Henriks-Eckerman ML, Suhonen R. Allergic contact dermatitis from phenoxyethoxy ethylacrylates in optical fiber coating, and glue in an insulin pump set. Contact Dermatitis 2001; 45: 36-7.
75. Boom BW, van Driel LM. Allergic contact dermatitis to epoxy resin infusion sets of an insulin pump. Contact Dermatitis 1985; 12: 280.
76. Geldof BA, Oranje AP, van Joost T. Hand eczema associated with continous subcutaneous insulin infusion. Contact Dermatitis 1989; 20: 384-5.
77. Corazza M, Marasini C, Aleotti A, Virgili A. Nickel contact dermatitis due to needle of an infusion pump, confirmed by microanalysis. Contact Dermatitis 1998; 39: 144.
78. Luch-Bernal M, Fernandez M, Herrera-Pombo JL, Sastre J. Insulin lispro, an alternative in insulin hypersensitivity. Allergy 1999; 54: 186-7.
79. Airaghi L, Lorini M, Tedeschi A. The insulin analog aspart a safe alternative in insulin allergy. Diabetes Care 2001; 24: 2000.
80. Silva ME, Mendes MI, Ursich MJ, Rocha DM, Brito AH, Fuki RT, Ruggeri GB, Nery M, Wajchenberg BL. Humain insulin allergy-immediate and late type III reactions in a long standing IDDM patient. Diabetes Res Clin Pract 1997; 36: 67-70.
81. Moriyama H, Nagata M, Fujihira K, Yamada K, Chowdhury SA, Chakrabarty S, Jin Z, Yasuda H, Ueda H, Yokono K. Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type I diabetes. Diabetes Care 2001; 24: 411-12.
82. Yasuda H, Nagata M, Moriyama H et al. Human insulin analog insulin aspart does not cause insulin allergy. Diabetes Care 2001; 24: 2008-9.
83. Kumar D. Lispro analog for treatment of generalized allergy to human insulin. Diabetes Care 1997; 20: 1357-9.
84. Frigerio C, Aubry M, Gomez F et al. Desensitization-resistant insulin allergy. Allergy 1997; 52: 238-9.
85. Abraham MR, aI-Sharafi BA, Saavedra GA, Khardori R. Lispro in the treatment of insulin allergy. Diabetes Care 1999; 22: 1916-17.
86. Eapen SS, Connor EL, Gern JE. Insulin desensitization with insulin lispro and an insulin pump in a 5 year-old child. Ann Allergy Asthma Immunol 2000; 85: 395-7.
87. Holdaway I, Wilson J. Cutaneous insulin allergy responsive to oral desensitisation and aspirin. Br Med J 1984; 289: 1565-6.
88. Patterson R, Grammer LC. Allergic diseases: Diagnosis and Management, ed 5. Philadelphia, Lippincott-Raven Publishers, 1997, p 389.
89. Wessbecher R, Kiehn M, Stoffel E, Moll I. Management of insulin allergy. Allergy 2001; 56: 919-20.
90. Galloway J.A., de Bressler R. Insulin treatment in diabetes. Med Clin North Am 1978; 62: 663-80.
91. Vialettes B. L'allergie à l'insuline. Diabète et Métabolisme 1986; 12: 359-62.
92. Rocklin RE, Sheffer AL, Greineder DK, Melmon KL. Generation of antigen specific supressor cells during allergy desensitization. N Eng J Med 1980; 302: 1213-19.